Biocryst Pharmaceuticals (BCRX) Prepaid Assets (2010 - 2026)

Biocryst Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $19.1 million for Q1 2026.

• Quarterly Prepaid Assets rose 33.41% year-over-year to $19.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.1 million (up 33.41% YoY) and the FY2025 annual result came in at $17.2 million, up 24.94% from the prior year.
• Prepaid Assets was $19.1 million for Q1 2026 at Biocryst Pharmaceuticals, up from $17.2 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $20.0 million in Q3 2023 and bottomed at $11.1 million in Q2 2022.
• A 5-year average of $15.3 million and a median of $15.2 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 108.75% — and 2024, when it decreased 29.63%.
• Biocryst Pharmaceuticals' Prepaid Assets stood at $12.6 million in 2022, then surged by 55.27% to $19.5 million in 2023, then dropped by 29.63% to $13.8 million in 2024, then advanced by 24.94% to $17.2 million in 2025, then gained by 11.24% to $19.1 million in 2026.
• Business Quant data shows BCRX's Prepaid Assets at $19.1 million in Q1 2026, $17.2 million in Q4 2025, and $16.5 million in Q3 2025.